Ireland
--:--IST
Latest
Clinical Trials in Italy / NCT04903912
Recruiting Observational

Campania Registry On Peripheral Artery Disease

NCT04903912 · tracked via the Priya Life Science Italy tracker
Phase
Observational
Started
2021-05-01
Last updated
2021-05-27

Condition(s) studied

Peripheral Artery Disease

Investigational drug(s) / intervention(s)

Vascular ultrasound or other imaging methods according to current guidelinesLaboratory testsMedical treatment according to current guidelinesEndovascular od surgical peripheral revascularizations

Vascular ultrasound or other imaging methods according to current guidelines: Peripheral vascular ultrasound / ankle/brachial index / CT angiography / MR angiography / angiography

Laboratory tests: Metabolic profile and platelet reactivity

Medical treatment according to current guidelines: Antithrombotic drugs, lipid-lowering drugs, antihypertensive drugs, and pharmacotherapy to increase walking capacity according to current guidelines

Endovascular od surgical peripheral revascularizations: Endovascular od surgical peripheral revascularizations according to current guidelines

Study summary

The CAmpania REgistry on Peripheral Artery Disease (CARE-PAD) is a single-center observational study which has the purpose to collect clinical, laboratory, instrumental, procedural and follow-up data and to evaluate the outcome of peripheral artery disease (PAD) patients.

Eligibility

Sex
ALL
Min age
18 Years
Max age
90 Years
Healthy volunteers
No
Inclusion Criteria: Confirmed diagnosis of peripheral artery disease as follows (one or more of the following): * Intermittent claudication with presence of hemodynamically significant stenosis/occlusion of lower limb arteries or pathological ABI (≤ 0.90); * Critical limb ischemia with presence of hemodynamically significant stenosis/occlusion of lower limb arteries or pathological ABI (≤ 0.90); * Presence of carotid stenosis of at least 50%; * Presence abdominal aortic aneurysm (≥ 3 cm); * History of peripheral/carotid revascularization or of aortic aneurysm treatment. Exclusion Criteria: Refusal to sign the informed consent

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Department of Advanced Biomedical Sciences, University of Naples "Federico II" Naples Italy Recruiting

More Federico II University trials in Italy

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04903912 on ClinicalTrials.gov ↗ ← All trials in Italy